WO2013063305A3 - Directed cardiomyocyte differentiation of stem cells - Google Patents
Directed cardiomyocyte differentiation of stem cells Download PDFInfo
- Publication number
- WO2013063305A3 WO2013063305A3 PCT/US2012/061972 US2012061972W WO2013063305A3 WO 2013063305 A3 WO2013063305 A3 WO 2013063305A3 US 2012061972 W US2012061972 W US 2012061972W WO 2013063305 A3 WO2013063305 A3 WO 2013063305A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stem cells
- cardiomyocytes
- cardiac
- differentiation system
- small molecule
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Abstract
Disclosed is a fully chemically defined, small molecule-mediated, directed differentiation system that promotes differentiation of stem cells, including embryonic stem cells, induced pluripotent stem cells, and adult stem cells, such as human forms of these stem cell types, to ventricular cardiomyocytes in a highly efficient, reproducible and scalable fashion. Molecular characterization revealed the cardiomyocytes' progression through the sequential stages of cardiac fate specification. Phenotypic and electrophysiological analysis illustrated the generation of a highly pure population of cardiomyocytes (greater than 90%) exhibiting the expected physiological characteristics and response to cardioactive compounds. These data indicate that the directed differentiation system, through small molecule-mediated manipulation of developmental signaling pathways, generates a nearly pure population of functional ventricular cardiomyocytes from pluripotent stem cells. The disclosed differentiation system provides a platform to perform large-scale pharmacological screenings and provides a valuable source of cardiac progenitor cells and cardiomyocytes for cell replacement therapies in cardiac repair.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161551294P | 2011-10-25 | 2011-10-25 | |
US61/551,294 | 2011-10-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013063305A2 WO2013063305A2 (en) | 2013-05-02 |
WO2013063305A3 true WO2013063305A3 (en) | 2015-06-18 |
Family
ID=48168782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/061972 WO2013063305A2 (en) | 2011-10-25 | 2012-10-25 | Directed cardiomyocyte differentiation of stem cells |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013063305A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2615396T3 (en) | 2013-08-22 | 2017-06-07 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin | Method to produce cardiac muscle by engineering (EHM) |
EP3047019B1 (en) * | 2013-09-20 | 2019-07-03 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin | A method to direct differentiation of pluripotent stem cells into functional heart muscle |
WO2015058117A1 (en) * | 2013-10-18 | 2015-04-23 | Icahn School Of Medicine At Mount Sinai | Directed cardiomyocyte differentiation and ventricular specification of stem cells |
GB201412554D0 (en) * | 2014-07-15 | 2014-08-27 | Cambridge Entpr Ltd | In vitro mesodermal differentiation |
WO2017207576A1 (en) | 2016-06-01 | 2017-12-07 | Miltenyi Biotec Gmbh | Process for generation, identification and isolation of human pluripotent stem cell-derived cardiomyocytes and cardiomyocyte subpopulations |
CN108048550A (en) * | 2017-12-08 | 2018-05-18 | 南京医科大学 | A kind of Environmental Chemical Pollutants cardiac development toxicity assessment technical method |
CN108913655B (en) * | 2018-07-16 | 2022-07-15 | 浙江大学 | Method for establishing human-derived myocardial hypertrophy model based on pluripotent stem cell technology |
CN111778205B (en) * | 2019-04-04 | 2022-09-30 | 青岛百洋智心科技有限公司 | Human cardiac muscle cell separation reagent, culture medium, separation method and culture method |
GB201908180D0 (en) * | 2019-06-07 | 2019-07-24 | Francis Crick Institute Ltd | Therapy for heart disorders |
CN113337458A (en) * | 2021-06-02 | 2021-09-03 | 呈诺再生医学科技(珠海横琴新区)有限公司 | Method for improving yield and purity of pluripotent stem cells directionally induced cardiac muscle cells |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080187494A1 (en) * | 2005-09-12 | 2008-08-07 | Es Cell International Pte Ltd | Cardiomyocyte Production |
US20110097799A1 (en) * | 2009-10-19 | 2011-04-28 | Casey Stankewicz | Cardiomyocyte production |
US20110212061A1 (en) * | 2002-05-17 | 2011-09-01 | Mount Sinai School Of Medicine Of New York University | Mesoderm and Definitive Endoderm Cell Populations |
-
2012
- 2012-10-25 WO PCT/US2012/061972 patent/WO2013063305A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110212061A1 (en) * | 2002-05-17 | 2011-09-01 | Mount Sinai School Of Medicine Of New York University | Mesoderm and Definitive Endoderm Cell Populations |
US20080187494A1 (en) * | 2005-09-12 | 2008-08-07 | Es Cell International Pte Ltd | Cardiomyocyte Production |
US20110097799A1 (en) * | 2009-10-19 | 2011-04-28 | Casey Stankewicz | Cardiomyocyte production |
Non-Patent Citations (2)
Title |
---|
BURRIDGE ET AL.: "A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline Variability.", PLOS ONE., vol. 6, no. 4, 8 April 2011 (2011-04-08), pages E18293, XP009167975, DOI: doi:10.1371/journal.pone.0018293 * |
ZHANG ET AL.: "Dedifferentiation and Proliferation of Mammalian Cardiomyocytes.", PLOS ONE., vol. 5, no. 9, 2010, pages E12559 * |
Also Published As
Publication number | Publication date |
---|---|
WO2013063305A2 (en) | 2013-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013063305A3 (en) | Directed cardiomyocyte differentiation of stem cells | |
WO2011149762A3 (en) | Method of nociceptor differentiation of human embryonic stem cells and uses thereof | |
WO2011130675A3 (en) | Dopaminergic neurons differentiated from pluripotent stem cells and uses of thereof | |
WO2015065524A3 (en) | Suspension and clustering of human pluripotent stem cells for differentiation into pancreatic endocrine cells | |
WO2011096728A3 (en) | Method for proliferating stem cells by activating c-met/hgf signaling and notch signaling | |
Javed et al. | Temporal progression of retinal progenitor cell identity: implications in cell replacement therapies | |
WO2015108944A3 (en) | Stem cell-derived hepatocytes in co-culture and uses thereof | |
WO2017049240A8 (en) | Selection of pluripotent cells for production of fertile xy female mice | |
McIntyre et al. | Gli3-mediated hedgehog inhibition in human pluripotent stem cells initiates and augments developmental programming of adult hematopoiesis | |
WO2009058451A3 (en) | Neuronal progenitor cells and methods of derivation and purification of neuronal progenitor cells from embryonic stem cells | |
WO2009155301A3 (en) | Multipotent neural cells | |
WO2014012115A3 (en) | Method for inducing cells to less mature state | |
IN2012DN06432A (en) | ||
Foo | Purification and culture of astrocytes | |
WO2009152482A3 (en) | Directed differentiation and maturation of stem cell-derived cardiomyocytes | |
Liu et al. | Effect of bFGF on fibroblasts derived from the golden snub-nosed monkey | |
Wei et al. | Comparison of different human cell derived induced pluripotent stem cells and embryonic stem cells in tuning embryoid body differentiation | |
Chanthra et al. | Maturity of pluripotent stem cell-derived cardiomyocytes and future perspectives for regenerative medicine | |
Xue et al. | Changes of biological characteristics and gene expression profile of umbilical cord mesenchymal stem cells during senescence in culture | |
Kishore et al. | A Comprehensive View on the Progress of Organoid Research with an Emphasis on its Relevance to Disease Characterization | |
WO2010065546A3 (en) | MAINTENANCE/EXPANSION OF HSCs | |
Kobayashi et al. | From cell therapy to organ regeneration therapy: generation of functional organs from pluripotent stem cells | |
Wei | BRICS Mechanism and International Financial Governance Reform | |
Longoni et al. | Mesenchymal stem cell-based immunomodulation in allogeneic heterotopic heart-lung transplantation. | |
Severino et al. | Secretome profiling of mouse embryonic mesencephalon mes-c-myc A1 cell line during neural differentiation by shot-gun LC-MS/MS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12842821 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12842821 Country of ref document: EP Kind code of ref document: A2 |